Dionex Corporation (DNEX)

[buhg1b]

Biotechnology instrumentation market to reach $4.6 billion by 2010

April 25, 2008 -- /PRWEB/ -- SAN JOSE, CA -- Demand for faster and more economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics, and combinatorial chemistry industries have led to the advancement of biotechnology instrumentation in recent years. Growth is likely to be supported by major technological innovations in almost all the sectors, especially in chip-based products. Innovations in DNA sequencers, including single-molecule detection technologies, are likely to increase read lengths, decrease out-of-phase chemistry issues, and simplify sample preparation processes. With several drugs set for patent expiration in the near future, enhanced research activity for development of new drugs has escalated the demand for electrophoresis instruments.

The United States and Europe collectively dominate the worldwide biotechnology instrumentation market with an estimated 70 percent share of sales in 2008 as stated by Global Industry Analysts, Inc. Focus is largely centered on development of more advanced, smaller, faster, and highly automated analytical instruments that integrate analytical technologies. In the United States, demand for advanced instruments with more throughput abilities is rising across all academic and pharmaceutical laboratories due to the shift of research focus towards proteomics. The protein/ peptide synthesizers market in the United States is projected to be the fastest growing segment.

Europe, Germany, the United Kingdom, and France represent the major markets, accounting for about a 55 percent share of the biotechnology instrumentation market. Germany occupies a pivotal position in the European biotech market. The DNA sequencers market in Germany is projected to reach $69 million by 2010. Asia-Pacific is expected to be the center of future growth in worldwide biotechnology instruments market with an impressive CAGR of 7 percent over the period 2000 to 2010. The HPLC equipment and supplies market in the region is estimated at $207 million for 2008.

Key players profiled in the report include Agilent Technologies Inc., Affymetrix, Applied Biosystems, Beckman Coulter, Bio-Rad Laboratories Inc., Dionex Corporation, GE HealthCare, Gilson Inc, Hitachi High-Technologies Corporation, Perkin-Elmer, Shimadzu Scientific Instruments Inc., Thermo Fisher Scientific Inc, Varian Inc., and Waters Corporation.

The report titled "Biotechnology Instrumentation: A Global Strategic Business Report," published by Global Industry Analysts, Inc., analyzes the market over the period 2000 to 2015. Product segments analyzed in the report include DNA synthesizers, protein/peptide synthesizers, DNA sequencers, protein/peptide sequencers, HPLC equipment and supplies, and electrophoresis equipment and supplies. The report reviews recent industry activity, technological innovations, and product introductions of major market participants across various segments.

Visit www.strategyr.com

http://cr.pennnet.com/display_article/326851/15/ARTCL/none/TOPST/1/Biotechnology-instrumentation-market-to-reach-$46-billion-by-2010/